Lv5
1010 积分 2020-10-02 加入
CAR T cell immunotherapy for human cancer
1个月前
已完结
Investigational Agents Targeting SGLT1 and SGLT2 in the Treatment of Type 2 Diabetes Mellitus
1个月前
已完结
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
1个月前
已完结
SGLT1 inhibition: Pros and cons
1个月前
已完结
Reflections on Advances in Cancer Research in 2024
3个月前
已完结
Precision Oncology: 2024 in Review
3个月前
已完结
Cancer in 2024
3个月前
已关闭
Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval
5个月前
已完结
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations
5个月前
已完结
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
6个月前
已完结
皖公网安备34019202002308
